BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15968543)

  • 1. Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary.
    Pauls K; Franke FE; Büttner R; Zhou H
    Virchows Arch; 2005 Sep; 447(3):603-9. PubMed ID: 15968543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
    Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of dysgerminomas from gonadoblastomas (report of 2 cases with XY gonadal dysgenesis)].
    Pickel H; Tscherne G
    Zentralbl Gynakol; 1987; 109(10):663-72. PubMed ID: 3617987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadoblastoma: an unusual ovarian tumor.
    Gorosito M; Pancera B; Sarancone S; Nocito AL
    Ann Diagn Pathol; 2010 Aug; 14(4):247-50. PubMed ID: 20637428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.
    Buell-Gutbrod R; Ivanovic M; Montag A; Lengyel E; Fadare O; Gwin K
    Pediatr Dev Pathol; 2011; 14(5):391-5. PubMed ID: 21682576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCT4: a novel biomarker for dysgerminoma of the ovary.
    Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
    Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of SALL4 and SF-1 in gonadoblastoma: useful markers in the identification of the invasive germ cell component.
    Bai S; Wei S; Ziober A; Yao Y; Bing Z
    Int J Gynecol Pathol; 2013 Jul; 32(4):379-83. PubMed ID: 23722510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
    Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
    Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine ovarian gonadoblastoma with dysgerminoma overgrowth: a case study and literature review.
    Flores AR; Lobo J; Nunes F; Rêma A; Lopes P; Carvalho L; Bartosch C; Amorim I; Gärtner F
    J Ovarian Res; 2019 Sep; 12(1):89. PubMed ID: 31547830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadoblastoma with contralateral dysgerminoma in a young female--a case report.
    Jadhav MN; Yelikar BR; Karigoudar M
    Indian J Pathol Microbiol; 2006 Apr; 49(2):274-6. PubMed ID: 16933739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Germinal cell tumors in young and adolescent girls].
    Rzepka-Górska I; Błogowska A; Zajaczek S; Zielińska D
    Ginekol Pol; 2003 Sep; 74(9):840-6. PubMed ID: 14674134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells.
    Jørgensen N; Müller J; Jaubert F; Clausen OP; Skakkebaek NE
    Histopathology; 1997 Feb; 30(2):177-86. PubMed ID: 9190360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical gonadoblastoma: its relationship to the 'dissecting' variant and undifferentiated gonadal tissue.
    Roth LM; Cheng L
    Histopathology; 2018 Mar; 72(4):545-555. PubMed ID: 28881049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadoblastoma: an immunohistochemical study and comparison to Sertoli cell nodule with intratubular germ cell neoplasia, with pathogenetic implications.
    Kao CS; Ulbright TM; Idrees MT
    Histopathology; 2014 Dec; 65(6):861-7. PubMed ID: 24766183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ cell neoplasms arising in gonadoblastomas.
    Hart WR; Burkons DM
    Cancer; 1979 Feb; 43(2):669-78. PubMed ID: 421188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation markers of Sertoli cells and germ cells in fetal and early postnatal human testis.
    Franke FE; Pauls K; Rey R; Marks A; Bergmann M; Steger K
    Anat Embryol (Berl); 2004 Dec; 209(2):169-77. PubMed ID: 15597196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undifferentiated gonadal tissue, Y chromosome instability, and tumors in XY gonadal dysgenesis.
    Beaulieu Bergeron M; Lemieux N; Brochu P
    Pediatr Dev Pathol; 2011; 14(6):445-59. PubMed ID: 21692598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging findings of ovarian dysgerminoma with emphasis on multiplicity and vascular architecture: pathogenic implications.
    Tsuboyama T; Hori Y; Hori M; Onishi H; Tatsumi M; Sakane M; Ota T; Tomiyama N
    Abdom Radiol (NY); 2018 Jul; 43(7):1515-1523. PubMed ID: 29450608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.